APC Anti-CYP27A1 antibody [EPR7529]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal CYP27A1 antibody - conjugated to APC.
View Alternative Names
CYP27, CYP27A1, Cytochrome P-450C27/25, Cytochrome P450 27, Sterol 27-hydroxylase, Vitamin D(3) 25-hydroxylase
Related conjugates and formulations (10)
-
578 PE
PE Anti-CYP27A1 antibody [EPR7529]
-
HRP Anti-CYP27A1 antibody [EPR7529]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-CYP27A1 antibody [EPR7529]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-CYP27A1 antibody [EPR7529]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-CYP27A1 antibody [EPR7529]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-CYP27A1 antibody [EPR7529]
-
603 Alexa Fluor® 568
Alexa Fluor® 568 Anti-CYP27A1 antibody [EPR7529]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-CYP27A1 antibody [EPR7529]
-
Anti-CYP27A1 antibody [EPR7529]
-
Anti-CYP27A1 antibody [EPR7529] - BSA and Azide free
Product details
This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link® conjugation technology, Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
How are conjugated primary antibodies validated?
This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling.
For suitable applications and species reactivity, please refer to the unconjugated version of this clone.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CYP27A1 participates in cholesterol catabolism. While it does not form large protein complexes it interacts with other enzymes in metabolic pathways. This enzyme initiates the acidic pathway of bile acid synthesis by converting cholesterol into 27-hydroxycholesterol. These transformations are important for maintaining cholesterol homeostasis and for producing bile acids that aid in fat digestion and nutrient absorption.
Pathways
CYP27A1 is central to the bile acid biosynthesis and cholesterol metabolism pathways. It collaborates with other enzymes such as CYP7A1 which is known for initiating the classic pathway of bile acid synthesis. Together they regulate cholesterol levels by metabolizing cholesterol into bile acids. Such pathways are critical in preventing cholesterol accumulation which could lead to various metabolic disorders.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com